Work

Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial

Year: 2013

Type: article

Source: Cancer Immunology Research

DOI: 10.1158/2326-6066.cir-13-0089

Authors: Takemasa Tsuji, Paul Sabbatini, Achim A. Jungbluth, Erika Ritter, Linda Pan, Gerd Ritter, Luis Ferran, David Spriggs, Andres M. Salazar, Sacha Gnjatic

Institutions: Roswell Park Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Ludwig Cancer Research, Cornell University, Ludwig Cancer Research, Ludwig Cancer Research, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Oncovir (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G589551644, G750820162

OpenAlex ID: W2142151289

FWCI: 2.366

Cites: 40

Cited by: 72

Related to: 10